Evidence map›Paper›PMID 26440539›Full record

SynthesisTranslational psychiatry2015

Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence.

D B Hancock, G W Reginsson, N C Gaddis, X Chen, N L Saccone, S M Lutz, B Qaiser, R Sherva, S Steinberg, F Zink and 24 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Translational psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 8 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 8 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Review
  10. Nicotine Motivated Behavior inInternational journal of molecular sciences · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Little Evidence of Modified Genetic Effect of rs16969968 on Heavy Smoking Based on Age of Onset of Smoking.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 17 institutions in 4 countries.

D B HancockBehavioral and Urban Health Program, Behavioral Health and Criminal Justice Research Division, Research Triangle Institute International, Research Triangle Park, NC, USA.
G W ReginssondeCODE Genetics/Amgen, Reykjavik, Iceland.
N C GaddisResearch Computing Division, Research Triangle Institute International, Research Triangle Park, NC, USA.
X ChenVirginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
N L SacconeDepartment of Genetics, Washington University in St. Louis, St. Louis, MO, USA.
S M LutzDepartment of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
B QaiserDepartment of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
R ShervaDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
S SteinbergdeCODE Genetics/Amgen, Reykjavik, Iceland.
F ZinkdeCODE Genetics/Amgen, Reykjavik, Iceland.
S N StaceydeCODE Genetics/Amgen, Reykjavik, Iceland.
C GlasheenBehavioral and Urban Health Program, Behavioral Health and Criminal Justice Research Division, Research Triangle Institute International, Research Triangle Park, NC, USA.
J ChenVirginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
F GuGenetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, United States Department of Health and Human Services, Bethesda, MD, USA.
B N FrederiksenIowa Department of Public Health, Des Moines, IA, USA.
A LoukolaDepartment of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
D F GudbjartssondeCODE Genetics/Amgen, Reykjavik, Iceland.
I BrüskeInstitute of Epidemiology I, German Research Center for Environmental Health, Neuherberg, Germany.
M T LandiGenetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, United States Department of Health and Human Services, Bethesda, MD, USA.
H BickeböllerDepartment of Genetic Epidemiology, University of Göttingen-Georg-August University Göttingen, Göttingen, Germany.
P MaddenDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
L FarrerDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
J KaprioDepartment of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
H R KranzlerDepartment of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
J GelernterDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
T B BakerCenter for Tobacco Research and Intervention, University of Wisconsin, Madison, WI, USA.
P KraftDepartment of Epidemiology, Harvard University School of Public Health, Boston, MA, USA.
C I AmosDepartment of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
N E CaporasoGenetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, United States Department of Health and Human Services, Bethesda, MD, USA.
J E HokansonDepartment of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
L J BierutDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
T E ThorgeirssondeCODE Genetics/Amgen, Reykjavik, Iceland.
E O JohnsonFellow Program and Behavioral Health and Criminal Justice Research Division, Research Triangle Institute International, Research Triangle Park, NC, USA.
K StefanssondeCODE Genetics/Amgen, Reykjavik, Iceland.
deCODE Genetics (Iceland) · ISRTI International · USUnited States Department of Health and Human Services · USUniversity of Helsinki · FIWashington University in St. Louis · USBoston University · USUniversity of Colorado Anschutz Medical Campus · USDartmouth College · USHarvard University · USHelmholtz Zentrum München · DEIowa Department of Public Health · USPhiladelphia VA Medical Center · USUniversity of Göttingen · DEUniversity of Nevada, Las Vegas · USUniversity of Wisconsin–Madison · USVirginia Commonwealth University · USYale University · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Testing Relapse Recovery Intervention ComponentsP01CA180945 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B, FIORE, MICHAEL C · 2014 to 2023
$23.0M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
Pharmacogenetic StudiesZIACP005804 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$11.1M
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare VariantsR01DA036583 · NIDA · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2014 to 2017
$3.0M
Utilizing Interaction to Identify Novel Genetic Factors for Nicotine DependenceR01DA035825 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI HANCOCK, DANA B · 2013 to 2015
$1.5M
CLINICAL/IMMUNOLOGIC/GENETIC ANALYSES OF AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROMEZ01AI000732 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI RAO, VEMULKONDA · 1995 to 2008
$1.1M
Common Genetic Pathways Underlying CVD and COPDK01HL125858 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI LUTZ, SHARON MARIE · 2015 to 2019
$721k
NCI NIH HHS P01 CA180945NCI NIH HHS P30 CA023108NHLBI NIH HHS K01 HL125858NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NIDA NIH HHS R01 DA035825NIDA NIH HHS R01 DA036583
6 · The paper itself

Abstract

We conducted a 1000 Genomes-imputed genome-wide association study (GWAS) meta-analysis for nicotine dependence, defined by the Fagerström Test for Nicotine Dependence in 17 074 ever smokers from five European-ancestry samples. We followed up novel variants in 7469 ever smokers from five independent European-ancestry samples. We identified genome-wide significant association in the alpha-4 nicotinic receptor subunit (CHRNA4) gene on chromosome 20q13: lowest P=8.0 × 10(-9) across all the samples for rs2273500-C (frequency=0.15; odds ratio=1.12 and 95% confidence interval=1.08-1.17 for severe vs mild dependence). rs2273500-C, a splice site acceptor variant resulting in an alternate CHRNA4 transcript predicted to be targeted for nonsense-mediated decay, was associated with decreased CHRNA4 expression in physiologically normal human brains (lowest P=7.3 × 10(-4)). Importantly, rs2273500-C was associated with increased lung cancer risk (N=28 998, odds ratio=1.06 and 95% confidence interval=1.00-1.12), likely through its effect on smoking, as rs2273500-C was no longer associated with lung cancer after adjustment for smoking. Using criteria for smoking behavior that encompass more than the single 'cigarettes per day' item, we identified a common CHRNA4 variant with important regulatory properties that contributes to nicotine dependence and smoking-related consequences.

Indexed as

FemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMalePolymorphism, Single NucleotideReceptors, NicotinicRNA Splice SitesTobacco Use DisorderWhite PeopleReceptors, NicotinicRNA Splice Sites

Identifiers

PMID26440539
PMCPMC4930126
OpenAlexW2212096717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.